Clinical Trial Update: A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

This Phase 4 trial compared subcutaneous brodalumab to oral dimethyl fumarate for adults with moderate to severe plaque psoriasis, and results were posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)
• brodalumab (brodalumab)

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2020-02-10